GMD — Antisera, Latex Agglutination, Cryptococcus Neoformans Class II
FDA product code GMD covers "Antisera, Latex Agglutination, Cryptococcus Neoformans", a Class II medical device regulated under 21 CFR 866.3165. Submissions are reviewed by the Microbiology panel. At least 10 recent 510(k) clearances have been granted under this product code.
Classification details
- Product Code
- GMD
- Device Class
- Class II
- Regulation Number
- 866.3165
- Submission Type
- 510(k) Exempt
- Review Panel
- MI
- Medical Specialty
- Microbiology
- Implant
- No
Recent 510(k) clearances
| K-Number | Applicant | Device Name | Date |
|---|---|---|---|
| K112422 | Immuno-Mycologics | CRAG LATERAL FLOW ASSAY (LFA) | Mar 28, 2012 |
| K102286 | Immuno-Mycologics | CRAG LATERAL FLOW ASSAY (CRAG LFA) | Jul 20, 2011 |
| K930418 | Trinity Laboratories | CRYPTO-LEX SYSTEM | Feb 17, 1994 |
| K933997 | Alexon Biomedical | PROSPECT ENTAMOEBA HISTOLYTICA MICROPLATE ASSAY | Nov 22, 1993 |
| K894845 | Meridian Diagnostics | (CALAS(TM)) W/ADD'L REAGENT CALAS(TM) PRONASE | Sep 8, 1989 |
| K812188 | American Scientific Products | CRYPTOCOCCAL ANTIGEN LATEX AGGLUTI | Aug 31, 1981 |
| K810510 | Immuno-Mycologics | YA-CRYPTO ANTIBODY TUBE AGGLUTINATION | Mar 20, 1981 |
| K792693 | Meridian Diagnostics | CRYPTOCOCCUS NEOFORMANS ANTISERUM, LATEX | Jan 21, 1980 |
| K791382 | Immuno-Mycologics | CRYPTOCOCCAL ANTIGEN LATEX AGGLUTINATION | Aug 16, 1979 |
| K780526 | I M | CRYPTOCOCCAL ANTIGEN LATEX AGG. SYSTEM | Apr 28, 1978 |